Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1991-8-15
|
pubmed:abstractText |
Mechanical cardiac valvular prostheses currently enjoy a 60% to 40% market-share advantage over tissue prostheses in the United States and worldwide. Only the Starr-Edwards caged Silastic (Dow Corning) ball, Medtronic-Hall, St. Jude Medical, and Omniscience valves remain available in the United States. Although each valve has certain advantages and disadvantages, no design has achieved functional mechanical perfection. Late follow-up of valve-related complications from the literature favors the St. Jude Medical and Medtronic-Hall valves.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0003-4975
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
161-72
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:2069453-Adolescent,
pubmed-meshheading:2069453-Aortic Valve,
pubmed-meshheading:2069453-Child,
pubmed-meshheading:2069453-Heart Valve Prosthesis,
pubmed-meshheading:2069453-Humans,
pubmed-meshheading:2069453-Mitral Valve,
pubmed-meshheading:2069453-Prosthesis Design,
pubmed-meshheading:2069453-Prosthesis Failure
|
pubmed:year |
1991
|
pubmed:articleTitle |
Mechanical cardiac valvular prostheses.
|
pubmed:affiliation |
Cardiac Surgical Unit, Massachusetts General Hospital, Boston 02114.
|
pubmed:publicationType |
Journal Article,
Review
|